- Home
- CLH vs TECH Comparison
CLH vs TECH Comparison
Compare CLH & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLH
- TECH
- Stock Information
- Founded
- CLH 1980
- TECH 1976
- Country
- CLH United States
- TECH United States
- Employees
- CLH N/A
- TECH N/A
- Industry
- CLH Environmental Services
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CLH Industrials
- TECH Health Care
- Exchange
- CLH Nasdaq
- TECH Nasdaq
- Market Cap
- CLH 13.9B
- TECH 11.3B
- IPO Year
- CLH 1987
- TECH 1989
- Fundamental
- Price
- CLH $250.02
- TECH $71.05
- Analyst Decision
- CLH Strong Buy
- TECH Buy
- Analyst Count
- CLH 9
- TECH 9
- Target Price
- CLH $258.11
- TECH $81.78
- AVG Volume (30 Days)
- CLH 399.4K
- TECH 1.2M
- Earning Date
- CLH 10-30-2024
- TECH 10-30-2024
- Dividend Yield
- CLH N/A
- TECH 0.45%
- EPS Growth
- CLH 15.34
- TECH N/A
- EPS
- CLH 7.68
- TECH 0.95
- Revenue
- CLH $5,797,005,000.00
- TECH $1,171,583,000.00
- Revenue This Year
- CLH $10.09
- TECH $7.67
- Revenue Next Year
- CLH $6.01
- TECH $9.38
- P/E Ratio
- CLH $32.59
- TECH $74.84
- Revenue Growth
- CLH 8.37
- TECH 2.41
- 52 Week Low
- CLH $158.42
- TECH $61.16
- 52 Week High
- CLH $267.11
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- CLH 49.55
- TECH 47.12
- Support Level
- CLH $240.00
- TECH $65.61
- Resistance Level
- CLH $265.72
- TECH $76.43
- Average True Range (ATR)
- CLH 6.02
- TECH 2.76
- MACD
- CLH -0.78
- TECH -0.60
- Stochastic Oscillator
- CLH 50.60
- TECH 35.81
About CLH Clean Harbors Inc.
Clean Harbors Inc is an environmental and industrial services provider. It provides parts cleaning and related environmental services to commercial, industrial, and automotive customers. Its business segments are Environmental Services and Safety-Kleen Sustainability Solutions. The company generates the majority of its revenues from the Environmental Services segment.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.